| Product ID |
Product Name |
CAS# |
Purity |
| Y3297333 |
KYN-101 |
2247950-73-6 |
98% |
| Y3295906 |
FTO-IN-3 |
2585198-87-2 |
99% |
| Y3136277 |
SHIN2 |
2204289-53-0 |
99.40% |
| Y3136240 |
VB124 |
2230186-18-0 |
95% |
| Y3136283 |
YH-53 |
1471484-62-4 |
98% |
| Y3138994 |
Antibacterial agent 27 |
65795-51-9 |
98.03% |
| Y3139033 |
TAK-020 |
1627603-21-7 |
99.93% |
| Y3290250 |
BMS-986278 |
2170126-74-4 |
99% |
| Y3291709 |
BAMEA-O16B |
2490668-30-7 |
98% |
| Y3138997 |
HeE1-2Tyr |
2245195-67-7 |
96% |
| Y3314093 |
HaloPROTAC-E |
2365478-58-4 |
97.05% |
| Y3139032 |
JAK2-IN-7 |
2593402-36-7 |
99% |
| Y3138974 |
Simufilam hydrochloride |
2480226-07-9 |
99.77% |
| Y3138972 |
AZD8154 |
2215022-45-8 |
99% |
| Y3139043 |
CK2 INHIBITOR 2 |
2641079-92-5 |
98% |
| Y3304927 |
TH1760 |
2567914-01-4 |
98% |
| Y3136483 |
SGC-CK2-1 |
2470424-39-4 |
99% |
| Y3305910 |
CBR-470-1 |
2416095-06-0 |
98% |
| Y3296848 |
WCK-4234 sodium |
1804915-68-1 |
98% |
| Y1253543 |
Trans-(1r,4r)-4-(pyridin-2-yloxy)cyclohexanecarbohydrazide |
1228087-48-6 |
95% |
| Y1253530 |
N-(8-AMINO-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)ACETAMIDE |
1179343-18-0 |
95% |
| Y3305708 |
1-Boc-4-PIPERIDINOL-2,2,6,6-D4 |
1014695-52-3 |
98% |
| Y3136468 |
(S,R,S)-AHPC-CO-C7-NH2 HCl |
2306389-04-6 |
95% |
| Y3136429 |
Phthalimidinoglutarimide-C5-OH |
2138441-34-4 |
93% |
| Y3314379 |
Phthalimidinoglutarimide-propargyl-C1-amine HCl |
2138440-40-9 |
95%+ |
| Y3136047 |
Lenalidomide-CO-C1-amine HCl |
444287-89-2 |
95% |
| Y3136011 |
Lenalidomide-C5-acid |
2338824-30-7 |
95% |
| Y3135984 |
(2R,5R)-1-(TERT-BUTOXYCARBONYL)-5-PHENYLPYRROLIDINE-2-CARBOXYLIC ACID |
2230901-01-4 |
95% |
| Y3136015 |
Tanuxiciclib |
1983983-64-7 |
98.0% |
| Y3287197 |
FHT-1015 |
2368903-18-6 |
98% |
| Y3136001 |
Imlunestrant |
2408840-26-4 |
99.02% |
| Y3136257 |
4-BROMO-5-METHYLOXAZOLE HCL |
2287288-05-3 |
95% |
| Y3136300 |
N-METHYL-4,5-DIHYDRO-1H-IMIDAZOL-2-AMINE |
930-53-0 |
95% |
| Y1257869 |
TEAD-IN-2 |
2563849-97-6 |
98% |
| Y1343320 |
2-AMINO-2-(3-CHLOROPHENYL)PROPAN-1-OL |
1179977-55-9 |
95% |
| Y3296481 |
L-Glyceric acid sodium |
146298-95-5 |
99% |
| Y3294282 |
4-[(1R)-1-Hydroxy-2-[methyl(phenylmethyl)amino]ethyl]-1,2-benzenediol |
317351-40-9 |
95% |
| Y1334023 |
tert-Butyl 2,2-dimethyl-5-oxopiperidine-1-carboxylate |
1894533-96-0 |
97% |
| Y3136416 |
4,4,5,5-TETRAMETHYL-2-(OXETAN-3-YLMETHYL)-1,3,2-DIOXABOROLANE |
2098279-67-3 |
95% |
| Y3308787 |
DBM-MMAF |
1810001-93-4 |
99.74% |
| Y3290943 |
GOAT-IN-1 |
1452473-54-9 |
99% |
| Y3310724 |
HIV-1 TAT (48-60) |
220408-24-2 |
99% |
| Y3136227 |
2-(prop-2-yn-1-yl)propane-1,3-diol |
771430-70-7 |
95% |
| Y3140820 |
4-bromo-1-methyl-3-(oxan-4-yl)-1H-pyrazole |
1506357-21-6 |
95% |
| Y3140805 |
2-(4-chloro-2-methoxyphenyl)-2-oxoacetic acid |
1891442-62-8 |
95% |
| Y3145251 |
[(5-bromo-2-chloropyridin-4-yl)methyl](methyl)amine |
2228169-88-6 |
95% |
| Y3145249 |
2-(4-bromo-3-fluorophenyl)propanenitrile |
1823790-62-0 |
95% |
| Y3145265 |
1-(2-bromoethyl)-2-(difluoromethoxy)benzene |
1342423-85-1 |
95% |
| Y3145250 |
2,2-difluoro-2-[4-fluoro-3-(trifluoromethyl)phenyl]acetic acid |
1965192-80-6 |
95% |
| Y3145260 |
1-[3-(difluoromethoxy)phenyl]cyclopropane-1-carbonitrile |
1314778-62-5 |
95% |
| Y1340212 |
4,4'-(Phenylimino)bisphenol |
25904-76-1 |
95%+ |
| Y3136583 |
1,4-difluoro-2-nitro-5-(trifluoromethyl)benzene |
1352458-13-9 |
95% |
| Y3291877 |
tert-butylN-(1,1-difluoro-4-oxobutan-2-yl)carbamate |
1029623-77-5 |
95% |
| Y3136320 |
4,4-difluorospiro[2.2]pentane-1-carboxylic acid |
2361635-28-9 |
95% |
| Y3136633 |
(4aR,7aS)-hexahydrofuro[3,4-b][1,4]dioxine-5,7-dione,cis |
876607-71-5 |
95% |
| Y1335437 |
2-Fluoro-6-methoxy-4-(methoxycarbonyl)phenylboronic Acid Pinacol Ester |
1962961-12-1 |
95% |
| Y3145412 |
[5-(methoxymethyl)-1,2-oxazol-3-yl]methanaminehydrochloride |
2243504-43-8 |
95% |
| Y3139017 |
BOS-318 |
2387633-15-8 |
98.11% |
| Y3139024 |
CHD1Li 6.11 |
2716890-91-2 |
98.50% |
| Y3139037 |
FAPI-2 |
2370952-98-8 |
98% |
| Y3287867 |
FPFT-2216 |
2367619-87-0 |
99% |
| Y3136255 |
R-GSK3685032 |
2170140-50-6 |
98.02% |
| Y3136260 |
Cedirogant |
2055496-11-0 |
99% |
| Y3136269 |
PF-998425 racemate |
1076225-26-7 |
99.68% |
| Y3305189 |
Inarigivir ammonium |
2172788-92-8 |
99% |
| Y3136248 |
ZL0590 |
2230496-99-6 |
99% |
| Y3288664 |
LY3405105 |
2326428-19-5 |
98% |
| Y3286950 |
PF-04802367 |
1962178-27-3 |
98% |
| Y3136272 |
HB007 |
2387821-46-5 |
99.20% |
| Y3138992 |
Antibacterial agent 26 |
75369-40-3 |
98.07% |
| Y3139003 |
Lipid A9 |
2036272-50-9 |
98.0% |
| Y3296399 |
ErSO |
2407860-35-7 |
99% |
| Y3139006 |
CL097 |
1026249-18-2 |
99.89% |
| Y3291011 |
JH-X-119-01 hydrochloride |
2591344-30-6 |
98% |
| Y3288485 |
CDK4/6-IN-6 |
2380321-51-5 |
98% |
| Y3289391 |
Glucocorticoid receptor modulator-1 |
2452396-89-1 |
99% |
| Y3138999 |
AZD-4694 |
1054629-49-0 |
99% |
| Y3305442 |
WCK-5153 |
1436862-38-2 |
98% |
| Y3138977 |
DLIN-KC3-DMA |
1217306-46-1 |
98.0% |
| Y3136527 |
MRTX849 acid |
2561529-96-0 |
99.84% |
| Y3285768 |
TP0586532 |
2427584-96-9 |
98% |
| Y3297115 |
EEDi-5285 |
2488952-40-3 |
99% |
| Y3296436 |
MKI-1 |
1190277-80-5 |
98% |
| Y3136426 |
([5-(5-Ethoxymethoxy-benzofuran-2-yl)-6-nitro-pyridin-2-yl]-methyl-carbamic acid tert-butyl ester) |
1211333-20-8 |
98% |
| Y3309127 |
GS-9667 |
618380-90-8 |
100% |
| Y3136492 |
(S,R,S)-AHPC-CO-C1-Br |
2379404-33-6 |
98% |
| Y3136454 |
(S,R,S)-AHPC-CO-C9-acid |
2172819-78-0 |
97.64% |
| Y3136542 |
(S,R,S)-AHPC-CO-C1-NH2 HCl |
2361120-26-3 |
98% |
| Y3290202 |
(S,R,S)-AHPC-CO-C7-acid |
2172819-76-8 |
98% |
| Y3313319 |
Thalidomide-O-acetamido-C5-amine HCl |
2360527-40-6 |
97% |
| Y3135989 |
Thalidomide-O-C6-azide |
2411389-65-4 |
99% |
| Y3135991 |
Pomalidomide-C3-OH |
2289788-04-9 |
95% |
| Y3135988 |
Pomalidomide-C2-OH |
1957235-61-8 |
95% |
| Y3291982 |
ML375 |
1488362-55-5 |
99% |
| Y3290434 |
KX-826 |
1272719-00-2 |
98% |
| Y3136016 |
D-1553 |
2559761-14-5 |
99% |
| Y3136250 |
5-(DIFLUOROMETHYL)PYRIDIN-3-OL |
1393541-20-2 |
95% |
| Y1257840 |
VU6000918 |
2101737-32-8 |
99% |
| Y1253394 |
DRAK2-IN-1 |
871837-60-4 |
99% |
| Y1253436 |
Abeprazan hydrochloride |
1902954-87-3 |
99% |